1. Home
  2. SPB vs IOVA Comparison

SPB vs IOVA Comparison

Compare SPB & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spectrum Brands Holdings Inc.

SPB

Spectrum Brands Holdings Inc.

HOLD

Current Price

$88.68

Market Cap

2.0B

Sector

Miscellaneous

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$5.11

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPB
IOVA
Founded
1906
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
SPB
IOVA
Price
$88.68
$5.11
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$82.40
$9.00
AVG Volume (30 Days)
309.0K
16.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
14.84
EPS
2.16
N/A
Revenue
$3,802,100,000.00
N/A
Revenue This Year
$2.03
$47.74
Revenue Next Year
$1.85
$40.31
P/E Ratio
$40.48
N/A
Revenue Growth
20.86
N/A
52 Week Low
$49.99
$1.76
52 Week High
$90.60
$5.64

Technical Indicators

Market Signals
Indicator
SPB
IOVA
Relative Strength Index (RSI) 57.14 58.76
Support Level $80.58 $3.77
Resistance Level $90.60 $5.63
Average True Range (ATR) 2.59 0.40
MACD 0.11 0.07
Stochastic Oscillator 70.80 64.45

Price Performance

Historical Comparison
SPB
IOVA

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: